tiprankstipranks
Clarivate Plc (CLVT)
NYSE:CLVT
Want to see CLVT full AI Analyst Report?

Clarivate (CLVT) AI Stock Analysis

300 Followers

Top Page

CLVT

Clarivate

(NYSE:CLVT)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$2.50
▼(-6.72% Downside)
Action:Reiterated
Date:06/09/26
Overall score reflects a company with improving operating profitability and strong free cash flow, but still pressured by ongoing net losses and significant recent revenue decline. Weak technicals (price below key moving averages and negative MACD) further weigh on the score, while the reaffirmed guidance and margin/FCF improvement plans are supportive but tempered by modest growth and cash-tax risk.
Positive Factors
High recurring revenue mix
A large and growing subscription mix (≈88%–90%) with improving renewal discipline (+100bps) increases revenue visibility and reduces cyclical transaction volatility. Over 2–6 months this supports predictable cash flows, easier forecasting, and higher lifetime customer value for incremental upsell.
Negative Factors
Sharp revenue decline
A material TTM revenue decline—partly from disposals—weakens scale benefits and raises questions about demand durability. If organic growth remains modest, margin gains may be insufficient to offset lost scale, pressuring long-term revenue-driven R&D and sales investment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
High recurring revenue mix
A large and growing subscription mix (≈88%–90%) with improving renewal discipline (+100bps) increases revenue visibility and reduces cyclical transaction volatility. Over 2–6 months this supports predictable cash flows, easier forecasting, and higher lifetime customer value for incremental upsell.
Read all positive factors

Clarivate (CLVT) vs. SPDR S&P 500 ETF (SPY)

Clarivate Business Overview & Revenue Model

Company Description
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scien...
How the Company Makes Money
Clarivate primarily makes money by selling subscription-based access to its data, analytics, and software/workflow platforms, along with related services. Key revenue streams typically include: (1) recurring subscriptions for research and academia...

Clarivate Earnings Call Summary

Earnings Call Date:Apr 29, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Aug 11, 2026
Earnings Call Sentiment Neutral
The call presented a mix of constructive operational and financial progress alongside material near-term headwinds. Highlights include margin expansion (adjusted EBITDA margin up ~200 bps to 41%), improved subscription mix (roughly 88%–89%), strengthened renewal discipline (+100 bps), AI-driven product adoption and efficiency gains, debt reduction actions and a reaffirmed full-year guidance with anticipated free cash flow growth to ~$400M. Offsetting these positives are modest organic growth rates (organic ACV 1.6%), Q1 free cash flow down $31M, transactional revenue softness, planned revenue reductions from disposals (~$100–130M), first-half timing pressure in patent renewals, and a potentially large cash tax increase disclosed in the call, which introduces meaningful near-term cash risk and uncertainty. Overall, the improvement trajectory and margin/cash generation outlook are encouraging, but the modest growth rates and several notable risks keep the picture balanced.
Positive Updates
Quarterly Revenue
Q1 revenue of $586 million, supported by continued VCP progress and favorable FX; management reaffirmed full-year revenue guidance (midpoint revenue expected ~$2.36 billion after planned disposals).
Negative Updates
Net Loss and Free Cash Flow Decline in Q1
Q1 net loss of $40 million (improved versus prior year), and free cash flow declined by $31 million versus prior year (Q1 FCF approx. $79M, down ~28% YoY), primarily due to higher working capital from incentive compensation payments.
Read all updates
Q1-2026 Updates
Negative
Quarterly Revenue
Q1 revenue of $586 million, supported by continued VCP progress and favorable FX; management reaffirmed full-year revenue guidance (midpoint revenue expected ~$2.36 billion after planned disposals).
Read all positive updates
Company Guidance
Clarivate reaffirmed its full-year guidance, forecasting organic ACV growth of 2%–3% (about +0.75 percentage points at the midpoint versus last year) with recurring organic revenue growth near 1.5% at the midpoint and overall organic growth about 1%; revenue is expected to decline to roughly $2.36 billion at the midpoint (about a $100M midpoint decline, with inorganic disposals reducing revenue by roughly $130M), while recurring organic revenue mix should improve to 88%–90%. They expect adjusted EBITDA to expand roughly 200 basis points to nearly a 43% margin at the midpoint and project adjusted diluted EPS of about $0.75 (≈+9% at the midpoint). Free cash flow is guided to roughly $400M (≈+10% or +$35M at the midpoint), with more than $1B of adjusted EBITDA converting to about $400M of FCF, an expected FX translation tailwind of ~$10M to revenue and ~$5M to EBITDA, cash interest improvement of ~ $20M, a working-capital use of ~$20M, a ~$10M paired-contract benefit, and ~$15M lower capex from disposals; the company expects to continue deleveraging (net leverage down from ~4.0x at Q1 to ~2.5x over a few years) and to redeploy FCF toward bond retirements.

Clarivate Financial Statement Overview

Summary
Mixed fundamentals: gross margin is strong and operating profitability is improving (EBIT positive; EBITDA margin rebounding), and free cash flow is sizable and positive. Offsetting this, the company is still net-loss making and TTM revenue decline is sharp, with leverage manageable but still meaningful.
Income Statement
46
Neutral
Balance Sheet
58
Neutral
Cash Flow
63
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.45B2.46B2.56B2.63B2.66B1.88B
Gross Profit1.63B1.62B1.69B1.72B1.71B1.25B
EBITDA929.10M828.70M456.60M-10.50M-3.01B532.15M
Net Income-137.40M-201.10M-636.70M-911.20M-3.96B-270.50M
Balance Sheet
Total Assets10.93B11.07B11.49B12.71B13.94B20.18B
Cash, Cash Equivalents and Short-Term Investments232.30M329.20M295.20M370.70M348.80M587.61M
Total Debt4.33B4.48B4.59B4.81B5.10B5.61B
Total Liabilities6.14B6.23B6.35B6.71B7.13B8.26B
Stockholders Equity4.79B4.84B5.14B5.99B6.81B11.93B
Cash Flow
Free Cash Flow597.10M365.30M357.50M501.70M306.40M205.30M
Operating Cash Flow592.00M628.50M646.60M744.20M509.30M323.80M
Investing Cash Flow-258.10M-263.20M-236.70M-237.40M57.30M-4.04B
Financing Cash Flow-448.80M-343.10M-470.10M-496.50M-759.20M4.03B

Clarivate Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.68
Price Trends
50DMA
2.53
Negative
100DMA
2.46
Negative
200DMA
3.06
Negative
Market Momentum
MACD
-0.08
Positive
RSI
35.89
Neutral
STOCH
7.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLVT, the sentiment is Negative. The current price of 2.68 is above the 20-day moving average (MA) of 2.46, above the 50-day MA of 2.53, and below the 200-day MA of 3.06, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 35.89 is Neutral, neither overbought nor oversold. The STOCH value of 7.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLVT.

Clarivate Risk Analysis

Clarivate disclosed 44 risk factors in its most recent earnings report. Clarivate reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Clarivate Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$24.72B11.1614.79%1.46%6.55%-3.10%
72
Outperform
$4.41B17.8927.16%13.35%18.39%
71
Outperform
$5.43B9.5922.44%1.41%6.47%10.82%
70
Outperform
$9.92B13.96119.81%2.30%-37.31%
67
Neutral
$4.98B13.2710.67%14.21%-2.92%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
51
Neutral
$1.41B-10.31-2.81%-3.25%78.91%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CLVT
Clarivate
2.21
-2.08
-48.48%
CTSH
Cognizant
52.17
-26.32
-33.53%
EPAM
Epam Systems
95.38
-77.20
-44.73%
EXLS
Exlservice Holdings
28.84
-19.34
-40.14%
IT
Gartner
148.17
-260.95
-63.78%
G
Genpact
32.06
-11.01
-25.56%

Clarivate Corporate Events

Business Operations and StrategyExecutive/Board Changes
Clarivate Announces New Intellectual Property Segment Leadership Change
Positive
Jun 8, 2026
Clarivate announced a leadership transition in its Intellectual Property segment, with former CPA Global CEO Simon Webster appointed President of the IP segment effective June 10, 2026, succeeding Maroun S. Mourad, who will depart his executive ro...
Executive/Board ChangesShareholder Meetings
Clarivate shareholders affirm directors, pay and auditors at AGM
Positive
May 18, 2026
Clarivate Plc held its 2026 Annual General Meeting of Shareholders on May 14, 2026, where 559,077,435 of 642,179,542 eligible ordinary shares were represented, constituting a quorum and underscoring strong shareholder participation. Shareholders e...
Business Operations and StrategyFinancial Disclosures
Clarivate Reports Q1 2026 Results, Reaffirms 2026 Outlook
Positive
Apr 29, 2026
On April 29, 2026, Clarivate reported first‑quarter 2026 results showing total revenue of $585.5 million, down 1.4% year on year due to disposals, but with 0.6% organic growth and a 1.6% rise in organic ACV, as subscription revenues grew 1.7...
Business Operations and StrategyExecutive/Board Changes
Clarivate Updates Executive Severance Plan and Equity Vesting
Neutral
Mar 26, 2026
On March 23, 2026, Clarivate’s board approved an Amended and Restated Executive Severance Plan, updating the executive protections originally put in place on June 30, 2021. The plan continues to cover members of the Executive Leadership Team...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 09, 2026